330940-23-3Relevant academic research and scientific papers
Anthranilamide-based N,N-dialkylbenzamidines as potent and orally bioavailable factor Xa inhibitors: P4 SAR
Zhang, Penglie,Bao, Liang,Fan, Jingmei,Jia, Zhaozhong J.,Sinha, Uma,Wong, Paul W.,Park, Gary,Hutchaleelaha, Athiwat,Scarborough, Robert M.,Zhu, Bing-Yan
scheme or table, p. 2186 - 2189 (2010/02/28)
Anthranilamide-based benzamidine compound 4 and its N-substituted analogs were designed and examined as factor Xa inhibitors using substituted benzamidines as unconventional S4 binding element. A group of N,N-dialkylbenzamidines (11, 17 and 24) have been
